Catheter Precision (VTAK) Free Cash Flow Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -1.82% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 226.77% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 9.73% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -51.69% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -109.40% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 133.09% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 363.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 108.16% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 29.12% |
| 10 | Catheter Precision | 2.01 Mn | 1.20 Mn | 390,000.00 | -19.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.66% |
| Dec 31, 2025 | 47.07% |
| Sep 30, 2025 | 21.13% |
| Jun 30, 2025 | -32.66% |
| Mar 31, 2025 | -17.46% |
| Dec 31, 2024 | -50.18% |
| Sep 30, 2024 | -51.17% |
| Jun 30, 2024 | 64.21% |
| Mar 31, 2024 | 83.76% |
| Dec 31, 2023 | 37.31% |
| Sep 30, 2023 | 63.13% |
| Jun 30, 2023 | 18.99% |
| Mar 31, 2023 | -41.09% |
| Dec 31, 2022 | 44.73% |
| Sep 30, 2022 | 32.55% |
| Jun 30, 2022 | 10.02% |
| Mar 31, 2022 | -5.82% |
| Dec 31, 2021 | 41.50% |
| Sep 30, 2021 | -21.30% |
| Jun 30, 2021 | -14.71% |
| Mar 31, 2021 | -14.52% |
| Dec 31, 2020 | 2.84% |
| Sep 30, 2020 | 22.32% |
| Jun 30, 2020 | 14.82% |
| Mar 31, 2020 | 22.37% |
| Dec 31, 2019 | -9.97% |
| Sep 30, 2019 | -81.05% |
| Jun 30, 2019 | -86.11% |
| Mar 31, 2019 | -257.92% |
| Dec 31, 2018 | -395.55% |